Aceto Corp (ACET) - Financial and Strategic SWOT Analysis Review

Aceto Corp (ACET) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH79834FSA
  • |
  • Pages: 53
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Aceto Corp (ACET)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aceto Corp (Aceto) is a distribution company that develops, markets, sells and distributes pharmaceutical intermediates, human health products and performance chemical products. The company's product portfolio includes finished dosage form generic pharmaceuticals, pharmaceutical active ingredients and intermediates, nutraceutical products, specialty performance chemicals including agricultural protection products and agricultural intermediates. It distributes several chemical compounds used primarily as finished products or raw materials in the agricultural, pharmaceutical, nutraceutical, coatings and industrial chemical industries. The company operates subsidiaries in the US, Germany, Luxembourg, China, the Netherlands, France, France, Hong Kong, Singapore, India, the UK and Philippines. Aceto is headquartered in Port Washington, New York, the US.

Aceto Corp Key Recent Developments

Sep 28,2018: ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results

Sep 12,2018: ACETO Announces Credit Agreement Amendment[Newswire : MarketLine-GNW]

Jul 16,2018: ACETO subsidiary Acetris Health receives favorable ruling regarding certain government contracts

Jun 22,2018: ACETO 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti Remind Investors with Losses in Excess of USD 100,000 of Deadline in Class Action Lawsuit Against Aceto

Jun 01,2018: Alan Levin Elected Chairman of the Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Aceto Corp-Key Facts 6

Aceto Corp-Key Employees 7

Aceto Corp-Key Employee Biographies 8

Aceto Corp-Major Products and Services 9

Aceto Corp-History 10

Aceto Corp-Company Statement 12

Aceto Corp-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 16

Company Overview 16

Aceto Corp-Business Description 17

Business Segment: Human Health Segment 17

Overview 17

Performance 17

Business Segment: Performance Chemicals Segment 17

Overview 17

Performance 17

Business Segment: Pharmaceutical Ingredients Segment 17

Overview 17

Performance 17

R&D Overview 18

Aceto Corp-Corporate Strategy 19

Aceto Corp-SWOT Analysis 20

SWOT Analysis-Overview 20

Aceto Corp-Strengths 20

Aceto Corp-Weaknesses 21

Aceto Corp-Opportunities 22

Aceto Corp-Threats 23

Aceto Corp-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Aceto Corp, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Sep 28, 2018: ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results 35

Sep 12, 2018: ACETO Announces Credit Agreement Amendment[Newswire : MarketLine-GNW] 38

Sep 12, 2018: ACETO Announces Credit Agreement Amendment[Newswire : MarketLine-GNW] 39

Jul 16, 2018: ACETO subsidiary Acetris Health receives favorable ruling regarding certain government contracts 40

Jun 22, 2018: ACETO 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti Remind Investors with Losses in Excess of USD 100,000 of Deadline in Class Action Lawsuit Against Aceto 41

Jun 01, 2018: Alan Levin Elected Chairman of the Board of Directors 42

May 03, 2018: ACETO Reports Fiscal 2018 Third Quarter Results 43

Apr 18, 2018: ACETO Board Takes Proactive Steps to Address Business and Financial Challenges 45

Feb 27, 2018: ACETO to Appeal U.S. Government Ruling Regarding Certain Lucid Pharma Contracts 46

Feb 01, 2018: ACETO Reports Fiscal 2018 Second Quarter Results 47

Section 6-Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53

List of Figures

Aceto Corp, Performance Chart (2013-2017) 29

Aceto Corp, Ratio Charts 31

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Aceto Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33

List of Tables

Aceto Corp, Key Facts 6

Aceto Corp, Key Employees 7

Aceto Corp, Key Employee Biographies 8

Aceto Corp, Major Products and Services 9

Aceto Corp, History 10

Aceto Corp, Subsidiaries 14

Aceto Corp, Key Competitors 24

Aceto Corp, Ratios based on current share price 25

Aceto Corp, Annual Ratios 26

Aceto Corp, Annual Ratios (Cont...1) 27

Aceto Corp, Annual Ratios (Cont...2) 28

Aceto Corp, Interim Ratios 30

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Aceto Corp, Recent Deals Summary 34

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Nutraceutical International Corporation

Lawson Products Inc

KMG Chemicals Inc

DKSH Holding Ltd.

Cambrex Corp

Calgon Carbon Corp

Balchem Corp

American Vanguard Corp

Aceto Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8916
Site License
USD 250 INR 17833
Corporate User License
USD 375 INR 26749

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com